The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals
2010

Nasal Ointment for Staphylococcus aureus Eradication in HIV Patients

Sample size: 100 publication Evidence: high

Author Information

Author(s): Gordon RJ, Chez N, Jia H, Zeller B, Sobieszczyk M, Brennan C

Primary Institution: HELP/PSI, Inc

Hypothesis

Does repeated nasal application of mupirocin ointment decrease the odds of S. aureus nasal colonization in HIV-infected individuals?

Conclusion

Monthly application of nasal mupirocin significantly decreased S. aureus colonization in HIV patients in residential drug rehabilitation.

Supporting Evidence

  • Mupirocin reduced the odds of monthly S. aureus nasal colonization by 83% compared with placebo.
  • Subjects colonized at study entry had a 91% reduction in subsequent colonization.
  • Mupirocin also suppressed S. aureus colonization in subjects not colonized at baseline.

Takeaway

Using a special ointment in the nose can help people with HIV not get a certain germ that can make them sick.

Methodology

A randomized, double-blinded, placebo-controlled study was conducted over an 8-month period.

Participant Demographics

HIV-positive patients at an in-patient drug rehabilitation center.

Statistical Information

P-Value

< 0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication